A comparative study on the equine and camelid antivenoms upon cardiovascular changes induced with
Camelid antivenom
Cardiovascular
Envenomation
Equine antivenom
Hemiscorpius lepturus
Journal
Iranian journal of basic medical sciences
ISSN: 2008-3866
Titre abrégé: Iran J Basic Med Sci
Pays: Iran
ID NLM: 101517966
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
ppublish
Résumé
In this study, the neutralizing abilities of the equine and the recently introduced camelid antivenoms on the hemodynamic parameters (inotropism, chronotropism, and arrhythmogenicity) were assessed following envenomation by At first, the electrophoretic profiles of both products were obtained by using the SDS-PAGE method (12.5%) and stained with Coomassie blue and silver nitrate. Secondly, different doses of the camelid antivenom (10, 50, and 100 µl) were given intravenously in 10 min before venom injection (400 µg/rat). The neutralizing potencies of camelid and equine antivenoms were measured by preincubation (100 µl) with Based on the electrophoretic profile, it was evident that undesired proteins significantly decreased in equine antivenom, owing to impurities. Pretreatment with the camelid antivenom (100 µl), neutralized the elevation of the mean arterial pressure evoked with scorpion venom injection (88.15±4.56 versus 10.2±1.23 percent at the 8th min). The Incubation of the venom and the camelid antivenom counteracted the hemodynamic changes, but the equine product had no effect. The intravascular injection of the equine antivenom transiently increased the mean arterial pressure as compared to the control (108.67±8.63 mmHg versus 52.67±1.93 mmHg at the 10 The most obvious finding emerging from this study was that the camelid antivenom neutralized the hemodynamic changes in rats significantly, but in comparison, the equine antivenom had just a minor ability.
Identifiants
pubmed: 32133062
doi: 10.22038/IJBMS.2019.14052
pmc: PMC7043884
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1440-1444Déclaration de conflit d'intérêts
None.
Références
Acta Trop. 2008 Aug;107(2):71-9
pubmed: 18579104
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Toxicon. 2010 Sep 15;56(4):596-603
pubmed: 20547172
Lancet. 1999 Sep 11;354(9182):906-9
pubmed: 10489950
Toxicon. 1994 Sep;32(9):1009-14
pubmed: 7801334
Toxicon. 2009 Mar 15;53(4):454-9
pubmed: 19708123
Chest. 1990 Jan;97(1):118-20
pubmed: 2295229
Toxicon. 2015 Dec 15;108:272-84
pubmed: 26522893
Toxicon. 2004 May;43(6):685-90
pubmed: 15109889
Toxicon. 2012 Oct;60(5):919-33
pubmed: 22750221
Toxicon. 2016 Apr;113:70-5
pubmed: 26809016
J Toxicol Clin Toxicol. 1992;30(2):245-58
pubmed: 1588674
Coll Antropol. 2011 Mar;35(1):249-58
pubmed: 21667541
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2955-2965
pubmed: 30309831
Toxicon. 2010 Sep 1;56(3):373-80
pubmed: 20412814
Toxicon. 1998 Nov;36(11):1523-8
pubmed: 9792168
N Engl J Med. 2014 Jul 31;371(5):457-63
pubmed: 25075837
Chest. 1970 Feb;57(2):156-62
pubmed: 5411717
J Pediatr. 1994 Jun;124(6):973-8
pubmed: 8201489
J Arthropod Borne Dis. 2018 Mar 18;12(1):31-40
pubmed: 30018992
J Pharmacol Exp Ther. 1974 Jan;188(1):207-13
pubmed: 4809270
EMBO J. 1998 Jul 1;17(13):3512-20
pubmed: 9649422
Toxicon. 2016 Apr;113:7-10
pubmed: 26836396
Indian J Nephrol. 2008 Oct;18(4):166-8
pubmed: 20142930
Iran J Pharm Res. 2014 Summer;13(3):743-56
pubmed: 25276176
Toxicon. 2010 Sep 15;56(4):521-5
pubmed: 20493200